Literature DB >> 11714702

Effects of modulation of glycerol kinase expression on lipid and carbohydrate metabolism in human muscle cells.

Eulàlia Montell1, Carlos Lerín, Christopher B Newgard, Anna M Gómez-Foix.   

Abstract

Glycerol is taken up by human muscle in vivo and incorporated into lipids, but little is known about regulation of glycerol metabolism in this tissue. In this study, we have analyzed the role of glycerol kinase (GlK) in the regulation of glycerol metabolism in primary cultured human muscle cells. Isolated human muscle cells exhibited lower GlK activity than fresh muscle explants, but the activity in cultured cells was increased by exposure to insulin. [U-(14)C]Glycerol was incorporated into cellular phospholipids and triacylglycerides (TAGs), but little or no increase in TAG content or lactate release was observed in response to changes in the medium glycerol concentration. Adenovirus-mediated delivery of the Escherichia coli GlK gene (AdCMV-GlK) into muscle cells caused a 30-fold increase in GlK activity, which was associated with a marked rise in the labeling of phospholipid or TAG from [U-(14)C]glycerol compared with controls. Moreover, GlK overexpression caused [U-(14)C]glycerol to be incorporated into glycogen, which was dependent on the activation of glycogen synthase. Co-incubation of AdCMV-GlK-treated muscle cells with glycerol and oleate resulted in a large accumulation of TAG and an increase in lactate production. We conclude that GlK is the limiting step in muscle cell glycerol metabolism. Glycerol 3-phosphate is readily used for TAG synthesis but can also be diverted to form glycolytic intermediates that are in turn converted to glycogen or lactate. Given the high levels of glycerol in muscle interstitial fluid, these finding suggest that changes in GlK activity in muscle can exert important influences on fuel deposition in this tissue.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11714702     DOI: 10.1074/jbc.M107227200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Effect of sucrose and saturated-fat diets on mRNA levels of genes limiting muscle fatty acid and glucose supply in rats.

Authors:  Andreu Ferrer-Martínez; Mario Marotta; Marco Turini; Katherine Macé; Anna M Gómez-Foix
Journal:  Lipids       Date:  2006-01       Impact factor: 1.880

2.  Aquaglyceroporins serve as metabolic gateways in adiposity and insulin resistance control.

Authors:  Amaia Rodríguez; Victoria Catalán; Javier Gómez-Ambrosi; Gema Frühbeck
Journal:  Cell Cycle       Date:  2011-05-15       Impact factor: 4.534

3.  Diacylglycerol kinase ε deficiency preserves glucose tolerance and modulates lipid metabolism in obese mice.

Authors:  Louise Mannerås-Holm; Milena Schönke; Joseph T Brozinick; Laurène Vetterli; Hai-Hoang Bui; Philip Sanders; Emmani B M Nascimento; Marie Björnholm; Alexander V Chibalin; Juleen R Zierath
Journal:  J Lipid Res       Date:  2017-02-28       Impact factor: 5.922

4.  Conserved family of glycerol kinase loci in Drosophila melanogaster.

Authors:  Julian A Martinez Agosto; Edward R B McCabe
Journal:  Mol Genet Metab       Date:  2006-03-20       Impact factor: 4.797

5.  Transcriptomic and network component analysis of glycerol kinase in skeletal muscle using a mouse model of glycerol kinase deficiency.

Authors:  Lola Rahib; Ganesh Sriram; Melissa K Harada; James C Liao; Katrina M Dipple
Journal:  Mol Genet Metab       Date:  2009-01-03       Impact factor: 4.797

6.  Hormone-sensitive lipase serine phosphorylation and glycerol exchange across skeletal muscle in lean and obese subjects: effect of beta-adrenergic stimulation.

Authors:  Johan W E Jocken; Carsten Roepstorff; Gijs H Goossens; Paula van der Baan; Marleen van Baak; Wim H M Saris; Bente Kiens; Ellen E Blaak
Journal:  Diabetes       Date:  2008-04-08       Impact factor: 9.461

Review 7.  Implications of Aquaglyceroporin 7 in Energy Metabolism.

Authors:  Francesco Maria Iena; Janne Lebeck
Journal:  Int J Mol Sci       Date:  2018-01-04       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.